Abstract: A fixing apparatus includes a belt, a rotary member, a pad member, and a slide member. A distance in the conveyance direction between a first position and a second position is 3.0 mm or less. The first position is a downstream edge of a tip of a projection positioned most downstream in a direction of rotation of the belt. The second position is an upstream edge, in the direction of rotation of the belt, of the guide portion that contacts with the inner circumference surface of the belt. A distance in the pressing direction between a third position and a fourth position is 0.4 mm or more and 2.0 mm or less. The third position is the tip of the projection positioned most downstream in the direction of rotation of the belt. The fourth position is the same position as the second position.

Abstract: Composition including (a) a fluoropolymer; and (b1) at least one of a compound represented by the formula (4) ((H—(CF2)7—COO)pM1) or the formula (4?) ((H—(CF2)8—COO)pM1) of the present disclosure, both respectively in an amount of 100 ppb or less relative to the fluoropolymer, or (b2) at least one of a compound represented by the formula (5) ((H—(CF2)13—COO)pM1) or the formula (5?) ((H—(CF2)14—COO)pM1) of the present disclose, both respectively in an amount of 100 ppb or less relative to the fluoropolymer.

Abstract: A fixing apparatus includes a belt, a steering roller, a slide member, and a pressing rotation member that forms a nip portion by pressing the belt and is disposed to face the slide member. The belt applies heat to a recording material and has an inner circumferential surface that receives a lubricant applied onto the inner circumferential surface. The pressing rotation member fixes a toner image onto the recording material by applying heat and pressure to an unfixed toner image in the nip portion, in cooperation with the belt. An end portion of the belt on one end side in a belt width direction takes a position outside an end portion of the slide member on the one end side and a position inside the end portion of the slide member on the one end side while the steering roller is in operation.

Abstract: The disclosure aims to provide a polytetrafluoroethylene fine powder containing less water and less impurities. Provided is a polytetrafluoroethylene fine powder substantially free from water and a fluorine-containing compound having a molecular weight of 1000 or less.

Abstract: The disclosure aims to provide a polytetrafluoroethylene powder for an electrode binder which is a sustainable product and can reduce or prevent gas generation inside a battery cell and deterioration of battery characteristics, an electrode binder, an electrode mixture, an electrode, and a secondary battery. Provided is a polytetrafluoroethylene powder for use as an electrode binder, the polytetrafluoroethylene powder being substantially free from water and a fluorine-containing compound having a molecular weight of 1000 or less.

Abstract: A control device included by a window driving device of the present invention is configured to: when a first operation to close a window is performed with an operation device located inside a vehicle, perform first drive control including drive control to close the window at a constant first speed in a first section located on an opening side more than a closing section located near a fully closed position of the window, and drive control to close the window at a lower speed than the first speed in the closing section; and when a second operation to close the window is performed with an operation device that can be carried outside the vehicle, perform second drive control including drive control to close the window at a lower speed than the first speed in the first section.

Abstract: Provided is an effective and safe method for treating or preventing a cancer using aAVC. The present invention finds suitable ranges of the dose of ?-GalCer loaded on aAVC cell surface, and the amount of ?-GalCer loaded on aAVC cell surface in a pharmaceutical composition comprising aAVC, which are preferred in terms of securing effectiveness and safety in the treatment and prevention of a cancer using aAVC, and provides an effective and safe method for treating or preventing a cancer using aAVC, aAVC for effective and safe treatment or prevention of a cancer, and a pharmaceutical composition comprising the same, etc.

Abstract: [Problem to be Solved] Provided is an effective and safe method for treating or preventing a cancer using aAVC. [Solution] The present invention finds suitable ranges of the dose of ?-GalCer loaded on aAVC cell surface, and the amount of ?-GalCer loaded on aAVC cell surface in a pharmaceutical composition comprising aAVC, which are preferred in terms of securing effectiveness and safety in the treatment and prevention of a cancer using aAVC, and provides an effective and safe method for treating or preventing a cancer using aAVC, aAVC for effective and safe treatment or prevention of a cancer, and a pharmaceutical composition comprising the same, etc.

Abstract: [Problem to be Solved] Provided is an effective and safe method for treating or preventing a cancer using aAVC. [Solution] The present invention finds suitable ranges of the dose of ?-GalCer loaded on aAVC cell surface, and the amount of ?-GalCer loaded on aAVC cell surface in a pharmaceutical composition comprising aAVC, which are preferred in terms of securing effectiveness and safety in the treatment and prevention of a cancer using aAVC, and provides an effective and safe method for treating or preventing a cancer using aAVC, aAVC for effective and safe treatment or prevention of a cancer, and a pharmaceutical composition comprising the same, etc.

Abstract: A vehicle system includes a drive source configured to generate torque for driving a vehicle, wheels including rear wheels that are primary driving wheels and front wheels that are auxiliary driving wheels, a torque distribution mechanism configured to distribute the torque of the drive source to the front wheels and the rear wheels, a steering wheel configured to be operated by a driver, and a controller configured to control at least the torque distribution mechanism. When the steering wheel is steered in reverse and a yaw rate difference related value related to a difference between a target yaw rate to be generated on the vehicle according to the steering of the steering wheel and an actual yaw rate actually generated on the vehicle is greater than or equal to a first predetermined value, the controller controls the torque distribution mechanism to reduce the torque distributed to the rear wheels.

Abstract: [Problem] A compound useful as an active ingredient of a pharmaceutical composition, for example, a pharmaceutical composition for cancer immunotherapy, and/or a pharmaceutical composition for immunological activation is provided. [Means for Solution] The present inventors have conducted intensive studies for the purpose of creating a pharmaceutical composition for cancer immunotherapy and/or a pharmaceutical composition for immunological activation.

Abstract: 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide or a pharmaceutically acceptable salt thereof has an excellent immunological activation effect, and a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof as an active ingredient is expected to be used as a pharmaceutical composition for cancer immunotherapy and/or as a pharmaceutical composition for immunological activation.

Abstract: The present invention provides: an InP wafer optimized from the viewpoint of small edge roll-off (ERO) and sufficiently high flatness even in the vicinity of a wafer edge; and a method for effectively producing the InP wafer. The InP wafer having a roll-off value (ROA) of from ?1.0 ?m to 1.0 ?m is obtained by using a method including: performing a first stage polishing under a processing pressure of from 10 to 200 g/cm2 for a processing time of from 0.1 to 5 minutes, while supplying a polishing solution containing bromine to at least one side of an InP single crystal substrate that will form the InP wafer; and performing a second stage polishing under a processing pressure of from 200 to 500 g/cm2 for a processing time of from 0.5 to 10 minutes, provided that the processing pressure is higher than that of the first stage polishing by 50 g/cm2 or higher.

Abstract: A seal member for sealing a gap between a car-side door sill and a landing-side door sill is slidable between a sealing position and a retracted position and is driven by a link mechanism. The seal member is connected to an actuation spring that receives a movement force toward the sealing position. The link mechanism releases engagement with the actuating member in synchronization with a start of a door open operation of the car door to permit sliding toward the sealing position caused by the actuation spring. The link mechanism is engaged with the actuating member of the car door side in synchronization with movement of the car door toward a door close end to move the seal member to the retracted position resisting to the actuation spring.

Abstract: The present invention provides: an InP wafer optimized from the viewpoint of small edge roll-off (ERO) and sufficiently high flatness even in the vicinity of a wafer edge; and a method for effectively producing the InP wafer. The InP wafer having a roll-off value (ROA) of from ?1.0 ?m to 1.0 ?m is obtained by using a method including: performing a first stage polishing under a processing pressure of from 10 to 200 g/cm2 for a processing time of from 0.1 to 5 minutes, while supplying a polishing solution containing bromine to at least one side of an InP single crystal substrate that will form the InP wafer; and performing a second stage polishing under a processing pressure of from 200 to 500 g/cm2 for a processing time of from 0.5 to 10 minutes, provided that the processing pressure is higher than that of the first stage polishing by 50 g/cm2 or higher.

Abstract: [Problem] A compound useful as an active ingredient of a pharmaceutical composition, for example, a pharmaceutical composition for cancer immunotherapy, and/or a pharmaceutical composition for immunological activation is provided. [Means for Solution] The present inventors have conducted intensive studies for the purpose of creating a pharmaceutical composition for cancer immunotherapy and/or a pharmaceutical composition for immunological activation.

Abstract: A seal member for sealing a gap between a car-side door sill and a landing-side door sill is slidable between a sealing position and a retracted position and is driven by a link mechanism. The seal member is connected to an actuation spring that receives a movement force toward the sealing position. The link mechanism releases engagement with the actuating member in synchronization with a start of a door open operation of the car door to permit sliding toward the sealing position caused by the actuation spring. The link mechanism is engaged with the actuating member of the car door side in synchronization with movement of the car door toward a door close end to move the seal member to the retracted position resisting to the actuation spring.

Abstract: In an MRI apparatus, RF shimming is performed with high precision in a short time irrespective of an object and an imaging mode. A database storing the shim parameter according to a change from a criterion state in advance is included when a state in which an shim parameter is calculated is set as the criterion state of the objet in order to obtain a high-quality image. At the time of imaging, the shim parameter registered in the database in association with a change amount closest to a change amount from the criterion state is used. In the database, the shim parameter calculated from a previously measured result is registered.

Abstract: A level control circuit that generates output signal for level control includes: a control information storage that stores control information corresponding to a signal level, a control information circuit that outputs the output signal for level control corresponding to the signal level of a first input signal based on the control information stored in the control information storage; and an information update circuit that updates the control information of the control information storage according to the signal level of a second input signal.

Abstract: An optical output level control apparatus includes a detector configured to detect power of an input optical signal; an amplifier configured to amplify the input optical signal; a memory configured to store data that define a first curved line representing a relationship between the input power and a drive voltage of the amplifier for obtaining a first output level and data that defines a second curved line representing a relationship between the input power and the drive voltage of the amplifier for obtaining a second output level; a generator configured to correct at least one of the first and second curved lines and generate a target curved line representing a relationship between input power and a drive voltage of the amplifier for obtaining a target output level through interpolation based on the first and second curved lines at least one of which is corrected.